Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Walterfang

Showing results (181-190 of 213) with videos related to

Pageof 22
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|September 2, 2008
White matter volume changes in people who develop psychosisMark Walterfang, Philip K McGuire, Alison R Yung, et al.
Internal Medicine Journal|October 31, 2022
Cerebrospinal fluid neurofilament light and cerebral atrophy in younger-onset dementia and primary psychiatric disordersNirbaanjot Walia, Dhamidhu Eratne, Samantha M Loi, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 21, 2014
The Australian, US, Scandinavian Imaging Exchange (AUSSIE): an innovative, virtually-integrated health research network embedded in health careJeffrey Cl Looi, Dennis Velakoulis, Mark Walterfang, et al.
Schizophrenia Research|October 20, 2009
Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophreniaLuca Cocchi, Mark Walterfang, Renée Testa, et al.
Journal of the Neurological Sciences|October 6, 2022
Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressorsDhamidhu Eratne, Michael Keem, Courtney Lewis, et al.
The Australian and New Zealand Journal of Psychiatry|June 22, 2019
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?Dhamidhu Eratne, Samantha M Loi, Nirbaanjot Walia, et al.
Neuroimage. Clinical|July 20, 2023
Structural and microstructural thalamocortical network disruption in sporadic behavioural variant frontotemporal dementiaDavid Jakabek, Brian D Power, Nicola Spotorno, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 16, 2022
A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementiaLucy Vivash, Charles B Malpas, Christian Meletis, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 7, 2013
Shape abnormalities of the caudate nucleus correlate with poorer gait and balance: results from a subset of the LADIS studyMatthew D Macfarlane, Jeffrey C L Looi, Mark Walterfang, et al.
Psychiatry Research. Neuroimaging|July 23, 2019
Striatal morphology and neurocognitive dysfunction in Huntington disease: The IMAGE-HD studyFiona A Wilkes, Zvart Abaryan, Chris R K Ching, et al.
Pageof 22

Showing results (181-190 of 213) with videos related to

Sort By:
Pageof 22
The British Journal of Psychiatry : the Journal of Mental Science|September 2, 2008
White matter volume changes in people who develop psychosisMark Walterfang, Philip K McGuire, Alison R Yung, et al.
Internal Medicine Journal|October 31, 2022
Cerebrospinal fluid neurofilament light and cerebral atrophy in younger-onset dementia and primary psychiatric disordersNirbaanjot Walia, Dhamidhu Eratne, Samantha M Loi, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 21, 2014
The Australian, US, Scandinavian Imaging Exchange (AUSSIE): an innovative, virtually-integrated health research network embedded in health careJeffrey Cl Looi, Dennis Velakoulis, Mark Walterfang, et al.
Schizophrenia Research|October 20, 2009
Grey and white matter abnormalities are associated with impaired spatial working memory ability in first-episode schizophreniaLuca Cocchi, Mark Walterfang, Renée Testa, et al.
Journal of the Neurological Sciences|October 6, 2022
Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressorsDhamidhu Eratne, Michael Keem, Courtney Lewis, et al.
The Australian and New Zealand Journal of Psychiatry|June 22, 2019
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?Dhamidhu Eratne, Samantha M Loi, Nirbaanjot Walia, et al.
Neuroimage. Clinical|July 20, 2023
Structural and microstructural thalamocortical network disruption in sporadic behavioural variant frontotemporal dementiaDavid Jakabek, Brian D Power, Nicola Spotorno, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 16, 2022
A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementiaLucy Vivash, Charles B Malpas, Christian Meletis, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 7, 2013
Shape abnormalities of the caudate nucleus correlate with poorer gait and balance: results from a subset of the LADIS studyMatthew D Macfarlane, Jeffrey C L Looi, Mark Walterfang, et al.
Psychiatry Research. Neuroimaging|July 23, 2019
Striatal morphology and neurocognitive dysfunction in Huntington disease: The IMAGE-HD studyFiona A Wilkes, Zvart Abaryan, Chris R K Ching, et al.
Pageof 22